Zeping Zuo Selected Research

ZY0511

6/2023	Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.
11/2021	Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
9/2021	The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
10/2019	Corrigendum to "ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway" [Cancer Lett. 454 (2019) 179-190].
10/2019	ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zeping Zuo Research Topics

Disease

11	Neoplasms (Cancer) 06/2023 - 01/2019
3	Inflammation (Inflammations) 06/2023 - 10/2016
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 10/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2021
2	Gliosis 10/2016 - 07/2015
1	Nociceptive Pain 12/2023
1	Pain (Aches) 12/2023
1	Migraine Disorders (Migraine) 06/2023
1	Hepatocellular Carcinoma (Hepatoma) 06/2023
1	Ulcerative Colitis 01/2023
1	Dehydration (Water Stress) 11/2022
1	Pheochromocytoma 01/2022
1	Anastomotic Leak 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2021
1	Rheumatoid Arthritis 05/2021
1	Multiple Sclerosis 05/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Memory Disorders (Memory Loss) 10/2016
1	Cognitive Dysfunction 10/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015

Drug/Important Bio-Agent (IBA)

5	ZY0511IBA 06/2023 - 10/2019
3	Lysine (L-Lysine)FDA Link 06/2023 - 10/2019
3	Dihydroorotate DehydrogenaseIBA 05/2021 - 01/2019
2	TabletsIBA 06/2023 - 01/2023
2	pyrimidineIBA 05/2021 - 01/2019
2	CytokinesIBA 10/2016 - 07/2015
2	Uric Acid (Urate)IBA 10/2016 - 07/2015
1	LigandsIBA 12/2023
1	Opioid Analgesics (Opioids)IBA 12/2023
1	Analgesics (Analgesic Drugs)IBA 12/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	Serotonin (5 Hydroxytryptamine)IBA 06/2023
1	Histone DemethylasesIBA 06/2023
1	Dextran SulfateIBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 11/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 11/2022
1	Glutathione (Reduced Glutathione)IBA 11/2022
1	Taurine FDA Link 11/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 11/2021
1	SphingolipidsIBA 11/2021
1	LipidsIBA 11/2021
1	ThymidineIBA 10/2021
1	Serine (L-Serine)FDA Link 10/2021
1	CarbonIBA 10/2021
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	purineIBA 10/2021
1	CopperIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	EnzymesIBA 01/2019
1	Toll-Like Receptor 4IBA 10/2016

Therapy/Procedure

6	Therapeutics 06/2023 - 10/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2023 - 01/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Sutures (Suture) 01/2022
1	Esophagectomy 01/2022
1	Drug Therapy (Chemotherapy) 10/2019
1	Injections 10/2016